MIXTURES OF COSMETIC UV ABSORBERSDisclosed are cosmetic or pharmaceutical composition comprising a UV filter combination of (a) an aqueous dispersion of 5,6,5′,6′-tetraphenyl-3,3′-(1,4-Phenylene)bis(1,2,4-Triazine) corresponding to the formula in particulate form; and(b) the UV filters selected from (b1) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine;(b2) Butyl Methoxydibenzoylmethane;(b3) Diethylhexyl Butamido Triazone;(b4) Ethylhexyl Triazone;(b5) Diethylamino Hydroxy Benzoyl Hexyl Benzoate;(b6) Ethyhexyl Methoxycinnamate;(b7) Ethylhexyl Salicylate;(b8) Homosalate;(b9) Octocrylene;(b10) Methylene Bis-Benzotriazolyl Tetramethylbutylphenol;(b11) Phenylbenzimidazole Sulfonic Acid;(b12) Titanium Dioxide;(b13) Tris-Biphenyl Triazine; and(b14) (2-{4-[2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl]-piperazine-1- carbonyl}-phenyl)-(4- diethylami- no-2-hydroxy-phenyl)-methanone;(b15) BBDAPT; Benzoic acid, 4,4′-[[6-[[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]-1 disiloxanyl]propyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-, dibutyl ester;(b16) benzylidene malonates; and(b17) merocyanine derivatives;(b18) Bis(butylbenzoate) diaminotriazine aminopropylsiloxane;(b19) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) encapsulated in a polymer matrix;(b20) 2-(2H-Benzotriazol-2-yl)-6-[(2-ethylhexyloxy)methyl]-4-methylphenol; and(b21) 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-methylphenyl ester.A cosmetic or pharmaceutical composition comprising a UV filter combination of (a) an aqueous dispersion of 5,6,5′,6′-tetraphenyl-3,3′-(1,4-Phenylene)bis(1,2,4-Triazine) corresponding to the formula in particulate form; and(b) the UV filters selected from the group consisting of (b1) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine;(b2) Butyl Methoxydibenzoylmethane;(b3) Diethylhexyl Butamido Triazone;(b4) Ethylhexyl Triazone;(b5) Diethylamino Hydroxy Benzoyl Hexyl Benzoate;(b6) Ethylhexyl Methoxycinnamate;(b7) Ethylhexyl Salicylate;(b8) Homosalate;(b9) Octocrylene;(b10) Methylene Bis-Benzotriazolyl Tetramethylbutylphenol;(b11) Phenylbenzimidazole Sulfonic Acid;(b12) Titanium Dioxide;(b13) Tris-Biphenyl Triazine;(b14) (2-{4-[2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl]-piperazine-1-carbonyl}-phenyl)-(4-diethylamino-2-hydroxy-phenyl)-methanone;(b15) BBDAPT; Benzoic acid, 4,4′-[[6-[[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]-1 disiloxanyl]propyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-, dibutyl ester;(b16) benzylidene malonates;(b17) merocyanine derivatives;(b18) Bis(butylbenzoate) diaminotriazine aminopropylsiloxane;(b19) Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) encapsulated in a polymer matrix;(b20) 2-(2H-Benzotriazol-2-yl)-6-[(2-ethylhexyloxy)methyl]-4-methylphenol; and(b21) 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-methylphenyl ester.wherein said composition contains at least two of the UV filters (b1)-(b17); andwherein said composition also contains a pharmaceutically or cosmetically acceptable excipient.
화장품 UV 흡수제의 혼합물(a) 미립자 형태의 화학식 (1)에 상응하는 5,6,5',6'-테트라페닐-3,3'-(1,4-페닐렌)비스(1,2,4-트리아진)의 수성 분산액; 및 (b) 하기로부터 선택된 UV 필터: (b1) 비스-에틸헥실옥시페놀 메톡시페닐 트리아진; (b2) 부틸 메톡시디벤조일메탄; (b3) 디에틸헥실 부타미도 트리아존; (b4) 에틸헥실 트리아존; (b5) 디에틸아미노 히드록시 벤조일 헥실 벤조에이트; (b6) 에틸헥실 메톡시신나메이트; (b7) 에틸헥실 살리실레이트; (b8) 호모살레이트; (b9) 옥토크릴렌; (b10) 메틸렌 비스-벤조트리아졸릴 테트라메틸부틸페놀; (b11) 페닐벤즈이미다졸 술폰산; (b12) 이산화티타늄; (b13) 트리스-비페닐 트리아진; 및 (b14) (2-{4-[2-(4-디에틸아미노-2-히드록시-벤조일)-벤조일]-피페라진-1-카르보닐}-페닐)-(4-디에틸아미노-2-히드록시-페닐)-메타논; (b15) BBDAPT; 벤조산, 4,4'-[[6-[[3-[1,3,3,3-테트라메틸-1-[(트리메틸실릴)옥시]-1 디실록사닐]프로필]아미노]-1,3,5-트리아진-2,4-디일]디이미노]비스-, 디부틸 에스테르; (b16) 벤질리덴 말로네이트; 및 (b17) 메로시아닌 유도체; (b18) 비스(부틸벤조에이트) 디아미노트리아진 아미노프로필실록산; (b19) 중합체 매트릭스 내에 캡슐화된 비스-에틸헥실옥시페놀 메톡시페닐 트리아진; (b20) 2-(2H-벤조트리아졸-2-일)-6-[(2-에틸헥실옥시)메틸]-4-메틸페놀; 및 (b21) 2-프로펜산, 3-(4-메톡시페닐)-, 2-메틸페닐 에스테르 의 UV 필터 조합물을 포함하는 화장품 또는 제약 조성물이 개시되어 있다.(a) 화학식 (1)에 상응하는 5,6,5',6'-테트라페닐-3,3'-(1,4-페닐렌)비스(1,2,4-트리아진)의 미립자 형태 수성 분산액; 및 (b) 하기로부터 선택된 UV 필터: (b1) 비스-에틸헥실옥시페놀 메톡시페닐 트리아진; (b2) 부틸 메톡시디벤조일메탄; (b3) 디에틸헥실 부타미도 트리아존; (b4) 에틸헥실 트리아존; (b5) 디에틸아미노 히드록시 벤조일 헥실 벤조에이트; (b6) 에틸헥실 메톡시신나메이트; (b7) 에틸헥실 살리실레이트; (b8) 호모살레이트; (b9) 옥토크릴렌; (b10) 메틸렌 비스-벤조트리아졸릴 테트라메틸부틸페놀; (b11) 페닐벤즈이미다졸 술폰산; (b12) 이산화티타늄; (b13) 트리스-비페닐 트리아진; 및 (b14) (2-{4-[2-(4-디에틸아미노-2-히드록시-벤조일)-벤조일]-피페라진-1-카르보닐}-페닐)-(4-디에틸아미노-2-히드록시-페닐)-메타논; (b15) BBDAPT; 벤조산, 4,4'-[[6-[[3-[1,3,3,3-테트라메틸-1-[(트리메틸실릴)옥시]-1 디실록사닐]프로필]아미노]-1,3,5-트리아진-2,4-디일]디이미노]비스-, 디부틸 에스테르; (b16) 벤질리덴 말로네이트; 및 (b17) 메로시아닌 유도체; (b18) 비스(부틸벤조에이트) 디아미노트리아진 아미노프로필실록산; (b19) 중합체 매트릭스 내에 캡슐화된 비스-에틸헥실옥시페놀 메톡시페닐 트리아진; (b20) 2-(2H-벤조트리아졸-2-일)-6-[(2-에틸헥실옥시)메틸]-4-메틸페놀; 및 (b21) 2-프로펜산, 3-(4-메톡시페닐)-, 2-메틸페닐 에스테르, 상기 조성물은 UV 필터 (b1)-(b17) 중 2개 이상을 함유하고  미용적으로 허용되는, 부형제를 함유하는 화장품 또는 제약 조성물.